BUSINESS
Sun Pharma gains on launching INFUGEM in US
Mumbai : Sun Pharmaceutical Industries is currently trading at Rs. 465.90, up by 3.20 points or 0.69% from its previous closing of Rs. 462.70 on the BSE. The…
Mumbai : Sun Pharmaceutical Industries is currently trading at Rs. 465.90, up by 3.20 points or 0.69% from its previous closing of Rs. 462.70 on the BSE. The…
Sun Pharmaceutical Industries’ wholly owned subsidiary — DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting…